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Soluble factors produced by PC-3 prostate cells decrease collagen content
and mineralisation rate in fetal rat osteoblasts in culture
JF Santib&anez, S Silva and J Martinez
Unidad de Biologia Celular, INTA, Universidad de Chile, Casilla 138-11, Santiago, Chile.
Summary Approximately 70% ofpatients with prostate cancer develop bone metastases in the advanced state
of the disease. In the present study, we sought to test the hypothesis that prostatic cancer cells produce factors
that inhibit the mineralisation process in vitro, decreasing the content of type I collagen in rat fetal calvaria
osteoblasts. We investigated the capacity ofconditioned media (CM) from the human prostatic tumour cell line
PC-3 to inhibit the expression of the differentiation programme on osteoblasts in culture, with a primary focus
on type I collagen synthesis and degradation. Our results show that PC-3 CM inhibits collagen synthesis and
stimulates the production ofinterstitial collagenase from osteoblasts. A consequential decrease in the content of
immunoreactive type I collagen was observed. We have previously demonstrated that PC-3 CM blocks
osteoblast differentiation in culture. We propose that under the effect of factors present in PC-3 CM,
osteoblastic cells retain the undifferentiated phenotype.
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The skeleton is the major site of metastasis for prostate
cancer (Chiarodo, 1991). This metastasis - generally asso-
ciated with poor prognosis - induces an osteoblastic reaction
in vitro, characterised by an increased osteoblast proliferation
(Koutsilieris et al., 1987a). In vivo, prostate cells produce a
sclerotic reaction in the infiltrated bone and impairment of
the mineralisation process (Charhon et al., 1983). The
decreased mineral deposition could be partly explained by a
decreased bioavailability of the nucleator proteins or by a
lower concentration of structural collagen (Roach, 1994).
Type I collagen constitutes the major extracellular matrix
protein of bone. It makes up between 60% and 70% of the
organic component and between 20% and 30% of its total
dry mass (Glimcher, 1984). Functionally, type I collagen has
been described as an essential protein for the architecture of
bone and the scaffold into which mineral is accumulated
(Bindermann et al., 1979). The relationships between collagen
accumulation and matrix mineralisation may be examined in
vitro as several reports have demonstrated the ability of
cultured osteoblasts to produce a calcified matrix (Escarot-
Charrier et al., 1983; Owen et al., 1990a,b). Studies using
transmission electron microscopy have demonstrated that
mineral deposition occurs in association with collagen fibres
(Gerstenfeld et al., 1988). Hence, any alteration of the
collagen architecture on the bone might result in an
impairment of mineralisation.
Using primary cultures of rat fetal calvaria osteoblasts, we
have previously shown that factor(s) present in medium
conditioned by the human prostatic cell line PC-3, stimulate
cell proliferation and block the differentiation pattern of
preosteoblasts (Martinez et al., 1996). As a result of this
treatment, cells retain traits of the undifferentiated precursors
expressing an unmineralised phenotype. Using the same
system, it has been shown that PC-3 CM stimulates
osteoblast proliferation by a mechanism that is different to
that of known bone mitogens transforming growth factor
(TGF-f,), insulin-like growth factor (IGF-I) and IGF-II
(Perkel et al., 1990). The aminoterminal end of the molecule
of urokinase-like plasminogen activator (u-PA), a component
of PC-3 CM, has been implicated as the main mitogenic
stimulus (Rabbani et al., 1990). In the present study, we
characterised the effect of soluble factors present in the
conditioned media from PC-3 cells on the mineralisation
process, particularly in collagen turnover of rat fetal calvaria
osteoblasts. Our results suggest that factors present in this
conditioned media inhibit the rate of synthesis of type I
collagen and stimulate the production by osseous cells of a
specific interstitial collagenase. We propose that the lower
accumulation product from the alteration of collagen
turnover rate could explain in part the inhibition of
mineralisation in rat fetal calvaria osteoblasts.
Materials and methods
Calvarial osteoblasts
Primary cultures of osteoblast-like cells from rat calvaria
were prepared essentially as indicated by Owen et al. (1990a).
Briefly, calvaria from fetal Wistar rats of 21 days of gestation
were isolated and incubated at 37°C in phosphate-buffered
saline (PBS) for 20 min. After this incubation, bones were
subjected to sequential digestion of 20, 40 and 90 min in a
mixture of 0.02% collagenase type II (Worthington, NJ,
USA) and 0.25% trypsin (Sigma, St Louis, MO, USA). Cells
from the first two digests were discarded and those released
from the third digestion were washed and plated in
Dulbecco's minimal essential medium (DMEM) (Sigma)
supplemented with 10% fetal calf serum (FCS; Gibco BRL
Gaithersburg, MD, USA) in 16 mm plates (Nunc, Roskilde,
Denmark) at a denisty of 5 x 104 cells per well. At confluency
(day 6), control cultures were fed with mineralisation medium
(MM) consisting of BGJb medium (Sigma) supplemented
with 10% FCS and 50 ig ml-' ascorbic acid and 10 mM p-
glycerol phosphate. Cells received this MM throughout the
experimental period. In experiments in which cultures were
treated with conditioned medium from prostate cells, the
medium was added from day 3 of culture at a final
concentration of 20 ig of total protein ml-'.
PC-3 cells
PC-3 cells correspond to a human prostate tumoral cell line
derived from a bone metastasis (Kaighn et al., 1989). These
cells grow in DMEM/F-12 culture medium enriched with
10% FCS and were purchased from The American Type
Culture Collection (ATCC), MD, USA.
In order to prepare conditioned medium (CM) from these
cells, confluent cultures were incubated for 48 h in a serum-
free DMEM/F-12 culture medium. Once collected, cell-free
CM was concentrated with polyethyleneglycol (MW 8000)
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until a concentration of 100-200 ig ml-'. Concentrated CM
was diluted with PBS and dialysed against PBS overnight
with a 10 kDa cut-off membrane.
Mineral histochemistry
In situ calcium phosphate determination was performed by
silver staining (Clark, 1981). Cellular monolayers were
washed twice with cold PBS and fixed with 10%
formaldehyde for 30 min. Once fixed, the cells were washed
with distilled water and incubated with 2% silver nitrate for
10 min in darkness. Cells were extensively washed with
distilled water and exposed to brilliant light for 15 min.
Cells were then dehydrated with ethanol (100%) and air-
dried.
Collagen synthesis
In these experiments CM from PC-3 prostate cells (PC-3) was
added (20 jug ml-') on day 4 of culture. Labelling was
performed during the last 48 h of each incubation time at
37°C with 5 pCi ml-' [3H]proline (20 Ci mmol-'; ICN
Biochemicals, Irvine, CA, USA) in a-MEM medium contain-
ing 1% FCS, and 50 Mg ml-' of both ascorbic acid and f,-
aminopropionitrile. After the labelling period, the culture
medium was harvested and processed for the determination
of labelled collagen and non-collagen proteins using a
collagenase-sensitive assay. This assay was performed using
collagenase type VII (Sigma), which is a high-purity,
chromatographically purified enzyme, and essentially free of
non-specific proteases. The net production of collagen,
represented by the amount of collagen (%) produced relative
to total [3H]proline protein synthesied, was calculated from
the formula: [3H]collagenase sensitive material x 100/[3H]
collagenase insensitive material x 5.4+[3H]collagenase-sensi-
tive material (Peterkofsy and Diegelmann, 1971).
Zymogram for interstitial collagenase
Sodium dodecyl sulphate-polyacrylamide (SDS-PAGE)
zymograms were prepared with 0.15 mg of type I collagen
per ml of gel. Samples normalised for cellular protein
concentration of serum-free CM from rat calvaria osteo-
blasts (day 11 of culture) were applied to gels and subjected
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to electrophoresis. The gels were washed twice with 2.5%
Triton X-100 for 30 min with mild shaking at room
temperature. The gels were incubated in 50 mM Tris-HCl,
pH 8.0, containing 10 mm calcium chloride and 50 mM
benzamidine at 25°C for 16 h. The gels containing type I
collagen were stained with 0.25% Coomassie blue R-250 in
50% methanol and 7.5% acetic acid for 30 min. Destaining
was performed with a solution of 10% methanol in 7.5%
acetic acid, and the proteolytic bands were visualised by
negative staining (MacKay et al., 1990).
Enzyme-linked immunoassay (ELISA) for type I collagen
Sample preparation Osteoblasts from days 6, 10, 13 and 18
of culture were released from culture plates with a rubber
policeman in 0.25% acetic-acid and sonicated at 23 kHZ.
The supernatant was incubated for 48 h at 4°C in a shaking
bath in order to solubilise collagen. Samples were neutralised
with PBS 10 x and total protein was determined by the
Bradford method (Bradford, 1976).
Plate preparation A stock solution (1 mg ml-') of type I
collagen (Sigma) in 0.25% acetic acid was diluted in cold PBS
at a final concentration of 5 Mg ml-'. In order to generate a
coating ofcollagen, 100 Ml of this solution was added to each
well and incubated overnight at 4°C. At the end of the
incubation time, the plates were washed twice with PBS/
0.05% Tween 20 (Sigma) and incubated for 1 h at room
temperature with PBS/1% BSA to block non-specific binding
sites. Finally, plates were washed twice with PBS/0.05%
Tween 20.
Aliquots of samples (10-20 Mg total protein ml-') and
collagen standards (0.01 - 10 Mg ml- ) were preincubated for
1 h at 4°C with an excess fixed amount of rabbit anti-type I
collagen antibody (1:500) (Biodesign International). This
antibody is specific for type I collagen. The resulting mixture
was added to plates coated with type I collagen and
incubated overnight at 4°C. Plates were washed three times
with PBS 0.05% Tween 20 and immobilised antigen-
antibody complex on the plate was revealed with a second
anti-rabbit goat antibody coupled to peroxidase. This second
complex was revealed with the OPD method measuring
absorbance at 492 nm (Voller et al., 1979).
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Figure 1 Histochemistry of rat fetal osteoblast. Control (upper row) and PC-3 CM-treated cells (lower row) were fixed and stained
with silver nitrate on days 6, 12, 18 and 23. Figure shows a representative result from three separate experiments. Original
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A competition binding curve using purified type I collagen
(standard) revealed a linear displacement of the antigen
throughout the entire concentration range used in this assay.
Results
4 shows, control cultures accumulate more immunoreactive
type I collagen than PC-3 CM-treated cultures throughout 3
weeks of culture.
Discussion
Mineral deposition during the entire differentiation period in
rat osteoblast cultures incubated in the presence or absence of
media conditioned by PC-3 cells (PC-3 CM), was visualised
by silver staining. As Figure 1 shows, nodules of mineral
deposition in control cultures start to appear from day 12 of
incubation and markedly increase with the time ofculture. In
contrast, PC-3 CM-treated cultures show only marginal
calcium accumulation. At the end of the experimental period
(23 days), few nodules ofmineralisation were observed in PC-
3 CM-treated cells. Calcium accumulation was 10-fold higher
in control cultures between days 5 and 23, whereas
accumulation was 2-fold higher in PC3-CM-treated cells
(data not shown, Martinez et al., 1996).
Collagen synthesis - an early marker of osteoblast
differentiation-was estimated as [3H]proline incorporation
into collagenase-sensitive proteins, and was measured on five
different days that represent different steps in the differentia-
tion pattern of osteoblasts. Results in Figure 2 show that
collagen synthesis increases from day 7 at the time when
ascorbic acid was added to the cultures, and decrease sharply
at day 15. PC-3 CM-treated cultures display a lower capacity
to synthesise collagen, which is more evident on days 9 and
11.
Osteoblast capacity to synthesise and release interstitial
collagenase was assessed in cultures incubated with increasing
concentrations of PC-3 CM. As Figure 3 shows, on day 11 of
culture osteoblasts in the absence of PC-3 CM release only a
small amount of active interstitial collagenase. In contrast,
osteoblasts incubated with increasing concentrations of PC-3
CM (from 5 to 30 ,ug ml-') secrete a significant amount of
active enzyme that increases in proportion to the concentra-
tion of PC-3 CM.
In order to confirm that the decreased synthesis and a
stimulated degradation rate result in a lower accumulation of
type I collagen in osteoblast cultures, we determined type I
collagen content in control and PC-3 CM cultures. As Figure
The experiments presented in this study were conducted to
investigate the effect of media conditioned by PC-3 cells on
interstitial collagen turnover of rat fetal calvaria osteoblasts
in culture, and the relationship of this phenomena with
osteoblast mineralisation.
PC-3 cells correspond to a cell line that secretes soluble
J.
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Figure 3 Type I collagen zymogram from cultured rat
osteoblasts. Samples of conditioned media from control (lane 6)
and PC-3 CM-treated rat osteoblasts were applied to a
polyacrylamide gel containing type I collagen as substrate. Lane
1 corresponds to a sample of PC-3 CM equivalent to 30pgml-'.
Lanes 2-5 represents samples of conditioned media from cells
treated with 30 (lane 2), 20 (lane 3), 10 (lane 4) and 5 (lane 5)
ugml-1 PC-3 CM. The figure represents typical results from three
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Figure 2 Type I collagen biosynthesis. Collagen synthesis
estimated as [3H]proline incorporation in collagenase-sensitive
proteins was measured as indicated in Materials and methods in
controls (O), and PC-3 CM-treated (0) fetal rat osteoblasts.
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Figure 4 Immunoreactive type I collagen accumulated in fetal
rat osteoblasts in culture. Cellular content of type I collagen in
control (0) and PC-3 CM-treated cells (0) was assessed
according to Materials and methods using a rabbit anti-type I
collagen antibody. Each point represents mean+s.e.m. of three
determinations.
,f F
_-Prostate-derived factors inhibit osteoblast mineralisation
JF Santib6fiez et at
421
factors that specifically stimulate osteoblast-like cells and has
been used as a model for the interaction between invasive
prostate cells and bone (Koutsilieris et al., 1987).
A reciprocal and functionally coupled relationship between
proliferation and differentiation has been proposed in rat
fetal calvaria cells in culture (Stein and Lian, 1993). A three-
step temporal pattern consisting of the amplification of a
proliferative pool, a period in which cells produce an
extracellular matrix and a period during which mineralisa-
tion occurs, has been defined (Owen et al., 1990a). In
addition we have previously characterised (Martinez et al.,
1996), using specific biochemical markers, that in our culture
system the early proliferative phase takes place between days
1 and 6, the extracellular matrix phase occurs during days 6
to 12 and the mineralisation phase takes place after day 12.
Therefore, the sampling days used in the present study are
representative of each one of these phases.
In a recent report, we demonstrated that rat fetal calvaria
osteoblasts in culture incubated with PC-3 CM do not
progress into the differentiation pathway, maintaining this
undifferentiated unmineralised phenotype. It is not yet clear if
this blockade on differentiation is the result of specific
inhibition of the differentiation pattern, or is the expression
of the maintenance of the cells in a proliferative status that
inhibits activation of differentiation genes (Martinez et al.,
1996).
Results from the present study indicate that osteoblast
cells cultured in the presence of PC-3 CM do not express the
mineralised phenotype and have a lower capacity to
synthesise collagen during the proliferative phase of the
culture. In addition, cells acquire the capacity to produce and
secrete an interstitial 65 kDa collagenase. As a consequence,
total accumulation of type I collagen decreases and
mineralisation does not take place.
A functional relationship between collagen synthesis
during the proliferation phase and the expression of the
osteoblast phenotype has been proposed by Owen et al.
(1990a). These studies point out that a lower deposition of
type I collagen caused by a low concentration of ascorbic
acid in the culture medium is associated with the maintenance
of a proliferative state. Furthermore, increased doses of
ascorbic acid resulted in a dose-dependent down-regulation
of proliferation, increased collagen synthesis and increased
mineralisation. In a recent report, Lynch et al. (1995)
measured osteoblast proliferation and gene expression
associated at the proliferative state, on cells attached on
type I collagen films. The authors described that cells seeded
in collagen proliferated at a lower rate, and genes normally
expressed at maximal levels during the proliferative period
were down-modulated. In these cases, external modifications
of the extracellular matrix (ECM) rate of synthesis produce a
regulation ofcell proliferation. Interestingly, our results could
represent an alternative to this view, i.e. an externally
produced prolongation of the proliferative state generates a
down-regulation of processes responsible for establishment of
collagen matrix.
Interstitial collagenase cleaves the native triple helix of
type I collagen into three-quarter- and one-quarter-length
fragments, which denature into randomly coiled polypeptide
chains at physiological temperature (Sakai and Gross, 1967).
Production of collagenase by bone cells is controlled by a
variety of bone-resorbing agents that include retinoic acid,
parathyroid hormone (PTH), 1,25-dihydroxyvitamin D3,
prostaglandin E2, interleukin 1 among others (Delaisse et
al., 1988; Varghesse et al., 1994). In cultured bone cells of
human origin it has been proposed that cell differentiation is
associated with a restrained capacity for metalloproteinase
biosynthesis (Rifas et al., 1994). In the fetal rat model,
however, there is no evidence that a similar phenomenon
occurs. Nevertheless, it is worth noting that: (a) the
transcription factor AP-1 is responsible for enhancing
transcription of collagenase in response to growth factors,
cytokines, tumour promoters, carcinogens and overexpression
ofcertain oncogenes (Angel and Karin, 1991), and (b) in fetal
rat osteoblasts in culture AP-1 binding activity is observed
primarily in the proliferating state and dramatically decreases
at the initiation of ECM maturation before mineralisation
(Owen et al., 1990b).
In our results, collagenase activity was measured on day
11, the time that corresponds to the maximum level of type I
collagen synthesis, and the point where the accumulation rate
of type I collagen begins to decrease in PC-3 CM-treated
cultures. At this stage, we observed that collagenase activity
in control cells is only marginal, which is in agreement with a
presumed genetic control of the transcription of the enzyme.
On the other hand, as we have proposed that fetal rat
osteoblasts cultured in the presence of PC-3 CM tend to
maintain the undifferentiated phenotype retaining some
proliferative status (Martinez et al., 1996), we suggest that
with these experimental conditions the expression of genetic
controls that down-regulated proliferation might not be fully
operative and therefore the stimuli on the expression of
interstitial collagenase would be maintained with the
consistent increase in activity.
Results described suggest that factor(s) present in PC-3
CM could alter collagen turnover in osteoblasts in culture. As
a result of this, two phenotypic traits are expressed: a lower
accumulation of type I collagen and the de novo expression
on an interstitial collagenase. Although no extensive
characterisation has been made regarding the factor(s)
present in PC3-CM that would be responsible for blockade
in osteoblast differentiation, we have observed that this
putative factor(s) is heat sensitive (100°C for 10 min), and has
a molecular weight larger than 10 kDa as it is retained by the
dialysing membrane.
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